Related Experiment Videos
[cis(Z)-Clopenthixol decanoate--a new depot neuroleptic]
International Pharmacopsychiatry
|January 1, 1982
Summary
Cis(Z)-Clopenthixol decanoate offers long-term treatment for chronic schizophrenia, effectively managing symptoms like hostility and restlessness. This thioxanthene neuroleptic provides sustained relief for 2-4 weeks per dose.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Background:
- Cis(Z)-Clopenthixol decanoate is a long-acting depot neuroleptic from the thioxanthene class.
- It is indicated for the long-term management of chronic schizophrenic patients.
Purpose of the Study:
- To review the chemistry, pharmacology, pharmacokinetics, dosage, and efficacy of cis(Z)-Clopenthixol decanoate.
- To highlight its therapeutic applications in psychiatric and substance use disorders.
Main Methods:
- Literature review of existing studies and clinical data.
- Analysis of pharmacological and pharmacokinetic profiles.
- Evaluation of clinical efficacy and symptom targeting.
Main Results:
- Demonstrates a duration of effect of 2-4 weeks, suitable for long-term therapy.
- Effectively targets symptoms such as hostility, suspiciousness, and psychomotor restlessness.
- Shows efficacy in hallucinatory-disintegrative and manic syndromes, and aids alcoholics with emotional stabilization and withdrawal symptom mitigation.
Conclusions:
- Cis(Z)-Clopenthixol decanoate is a valuable therapeutic option for chronic schizophrenia.
- Its broad efficacy extends to managing symptoms in alcohol dependence and withdrawal.
- The drug's pharmacokinetic profile supports its utility in long-term treatment strategies.